EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2000 participants.

Also called NCT01084993

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01084993
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01084993. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2018-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding
Acronym
EASY-B2B
Intervention (Drug)
Bivalirudin
Intervention (Drug)
Heparin
Lead sponsor
Laval University (class: other)

Record details

Record id
cardio:ct-nct01084993
Content hash
c99821ccedd73e2bd138e915cce6945c18d2ed499561860285285a1df722ff27